by Eric Christianson | Feb 9, 2025 | Cardiovascular Medication and Disease State Clinical Pearls
This video is part of a three-part series covering new literature that could influence clinical practice. In this video, I discuss whether beta-blocker use post-MI is beneficial for patients with HFpEF. Background about the mechanism of action and typical place in...
by Eric Christianson | Oct 15, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
At face value, metoprolol tartrate (brand name Lopressor) and metoprolol succinate (brand name Toprolol XL) may seem similar. They are both selective beta-1 adrenoceptor blockers, with tartrate being dosed twice daily and succinate being dosed once daily. However,...
by Eric Christianson | Aug 13, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
If you work with patients at all, you’ll see some of the most common antihypertensive agents used on a daily basis. The reason they are used so frequently is because they do not tend to have many significant drug interactions. However, some do exist and I wanted...
by Eric Christianson | Feb 12, 2023 | Clinical Guideline Updates For Pharmacists
Heart failure is a disease state that requires a significant number of medications. Guideline-based standards of care now include numerous medications. How did we get there? I outline my top 5 heart failure clinical trials of all time. Feel free to leave a comment if...
by Eric Christianson | Nov 9, 2022 | Uncategorized
Migraine headaches affect more than one billion individuals per year across the world and are often self-managed by over-the-counter pain relievers such as ibuprofen or aspirin, but sometimes can become debilitating to the point where prescription medications are...
